Skip to main content
. Author manuscript; available in PMC: 2013 Sep 27.
Published in final edited form as: Curr Top Microbiol Immunol. 2012;355:135–169. doi: 10.1007/82_2011_178

Fig. 1.

Fig. 1

The Ras-PI(3)K-mTOR pathway in GBM. Pathway members highlighted in red are mutated in human GBM tumor samples. Pathway inhibitors that have been or will be explored as therapeutics for GBM are indicated